‘Doin’ It’ Review: Lilly Singh’s High-School Sex-Ed Comedy Gets an Incomplete

United Kingdom News News

‘Doin’ It’ Review: Lilly Singh’s High-School Sex-Ed Comedy Gets an Incomplete
United Kingdom Latest News,United Kingdom Headlines
  • 📰 THR
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 53%

A 30something gets a job teaching sex ed to high schoolers despite the fact that she's still a virgin in this film co-written by Singh directed by Sarah Zandieh.

revolves around surely the most literal interpretation imaginable of the old saying “those who can, do; those who can’t, teach.”stars as Maya, who stumbles almost by accident into a job teaching sex ed, despite still being a virgin. As she schools her kids on everything from consent to gender identity to orgasms, Maya sets out to unlearn the shame that she herself internalized at that age — and maybe even to get laid for the first time.

Meanwhile, the film extends sincere empathy toward Maya’s struggle to internalize in private the sex-positive values she espouses in public. “I’m confident with everything else but when it comes to this stuff, it’s like I’m broken,” she cries after a date with a cute fellow teacher ends with her cruelly projecting her own fears about being “weak” and “prudish” onto him.

The opposition to her teachings is strangely toothless — none of the other parents or teachers even notice how drastically she’s strayed from the lesson plan for weeks, and once they do, the ensuing pushback plays out with more confusion than venom. It’s outside the scope of any one movie, let alone a lighthearted comedy like this one, to fix the state of sex ed in America.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

THR /  🏆 411. in US

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug resultsNovo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug resultsZealand Pharma's Phase 2 trial was an 'uniquivocal win' for a drug that can treat both liver disease and obesity, analysts said.
Read more »

Lilly Hiatt, Molly MartinLilly Hiatt, Molly MartinLilly Hiatt, Molly Martin at Beachland Tavern:
Read more »

In an unusual move, FDA postpones approval decision for Lilly’s Alzheimer’s drugIn an unusual move, FDA postpones approval decision for Lilly’s Alzheimer’s drugBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »

Eli Lilly's Alzheimer's drug delayed by FDA: ‘It was unexpected’Eli Lilly's Alzheimer's drug delayed by FDA: ‘It was unexpected’On Friday, the FDA announced it would postpone a decision on Eli Lilly's potential Alzheimer's treatment donanemab.
Read more »

Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Read more »

Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersEli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be delayed beyond the end of March as the FDA plans to call a last-minute meeting of its advisers
Read more »



Render Time: 2025-04-05 19:38:56